Vertex Pharmaceuticals, Inc.-1.521 %

Daily Stock Price

CEO

Reshma Kewalramani


Company Symbol

VRTX


Exchange

NASDAQ


Industry

Biotechnology


Information

Vertex Pharmaceuticals, Inc. engages in the business of discovering, developing, manufacturing and commercializing small molecule drugs for patients with serious diseases. It focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.


*latest update 2020-05-13

Monthly Stock Price

Financial Ratios

Institutional Holders

HolderSharesDate Reported% OutValue
FMR, LLC22,656,589Mar 30, 20208.74%5,391,135,352
Blackrock Inc.22,326,048Mar 30, 20208.61%5,312,483,121
Price (T.Rowe) Associates Inc21,623,906Mar 30, 20208.34%5,145,408,432
Vanguard Group, Inc. (The)20,608,939Mar 30, 20207.95%4,903,897,035
Capital World Investors12,579,718Mar 30, 20204.85%2,993,343,898
State Street Corporation11,449,243Mar 30, 20204.42%2,724,347,371
Wellington Management Company, LLP7,611,768Mar 30, 20202.94%1,811,220,195
Renaissance Technologies, LLC6,859,682Mar 30, 20202.65%1,632,261,331
Capital International Investors6,542,598Mar 30, 20202.52%1,556,811,194
AllianceBernstein, L.P.6,193,851Mar 30, 20202.39%1,473,826,845

Search a Stock from the NASDAQ 100

We are redirecting you to